Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan

Yi Hao Weng, Ya Wen Chiu, Shao Wen Cheng, Chun Yuh Yang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Hyperbilirubinemia is a common disorder during neonatal period in Taiwan. Gene variants may play an important role in the development of neonatal hyperbilirubinemia. The current study investigated the association between neonatal hyperbilirubinemia and common gene variants involving the production and metabolism of bilirubin. Methods: This prospective study enrolled 444 healthy infants born in the Chang Gung Memorial Hospital at Taipei from 2013-2015. Hyperbilirubinemia was defined as a total bilirubin = 15 mg/dL. A log-binomial model was used to assess the risk of gene variants. Results: The most common genetic variant was short heme oxygenase (HO)-1 promoter GT-allele (<24 repeats) (39.4 %), followed by GA at nt388 in hepatic solute carrier organic anion transporter 1B1 (SLCO1B1) (31.1 %), GA at nt211 in UDP-glucuronosyltransferase 1A1 (UGT1A1) (29.3 %), ABO incompatibility (16.2 %), alpha thalassemia (5.0 %), and G6PD deficiency (3.2 %). The log-binomial analysis demonstrated greater risks of hyperbilirubinemia in infants with GA at nt211 in UGT1A1 (RR = 1.548; 95 % CI = 1.096-2.187), short HO-1 promoter GT-repeat (RR = 2. 185; 95 % CI = 1.527-3.125), and G6PD deficiency (RR = 1.985; 95 % CI = 1.010-3.901). The other gene variants - including blood type, alpha thalassemia, and SLCO1B1 - carried no significant risk. Conclusions: G6PD deficiency, short HO-1 promoter GT-repeat and GA at nt211 in UGT1A1 are risk factors of neonatal hyperbilirubinemia. The data provide clinical evidence to explain the high incidence of neonatal hyperbilirubinemia in Taiwan.

Original languageEnglish
Article number144
JournalBMC Pediatrics
Volume16
Issue number1
DOIs
Publication statusPublished - 2016

Fingerprint

Neonatal Hyperbilirubinemia
Taiwan
Glucosephosphate Dehydrogenase Deficiency
Heme Oxygenase-1
Hyperbilirubinemia
alpha-Thalassemia
Bilirubin
Genes
Statistical Models
Alleles
Prospective Studies
Liver
Incidence
UGT1A1 enzyme
human SLCO1B1 protein

Keywords

  • Heme oxygenase-1
  • Hepatic solute carrier organic anion transporter 1B1
  • Neonatal hyperbilirubinemia
  • Thalassemia
  • UDP-glucuronosyltransferase 1A1

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan. / Weng, Yi Hao; Chiu, Ya Wen; Cheng, Shao Wen; Yang, Chun Yuh.

In: BMC Pediatrics, Vol. 16, No. 1, 144, 2016.

Research output: Contribution to journalArticle

Weng, Yi Hao ; Chiu, Ya Wen ; Cheng, Shao Wen ; Yang, Chun Yuh. / Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan. In: BMC Pediatrics. 2016 ; Vol. 16, No. 1.
@article{d09bd4b488ef4306ae1a086f085ad3a4,
title = "Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan",
abstract = "Background: Hyperbilirubinemia is a common disorder during neonatal period in Taiwan. Gene variants may play an important role in the development of neonatal hyperbilirubinemia. The current study investigated the association between neonatal hyperbilirubinemia and common gene variants involving the production and metabolism of bilirubin. Methods: This prospective study enrolled 444 healthy infants born in the Chang Gung Memorial Hospital at Taipei from 2013-2015. Hyperbilirubinemia was defined as a total bilirubin = 15 mg/dL. A log-binomial model was used to assess the risk of gene variants. Results: The most common genetic variant was short heme oxygenase (HO)-1 promoter GT-allele (<24 repeats) (39.4 {\%}), followed by GA at nt388 in hepatic solute carrier organic anion transporter 1B1 (SLCO1B1) (31.1 {\%}), GA at nt211 in UDP-glucuronosyltransferase 1A1 (UGT1A1) (29.3 {\%}), ABO incompatibility (16.2 {\%}), alpha thalassemia (5.0 {\%}), and G6PD deficiency (3.2 {\%}). The log-binomial analysis demonstrated greater risks of hyperbilirubinemia in infants with GA at nt211 in UGT1A1 (RR = 1.548; 95 {\%} CI = 1.096-2.187), short HO-1 promoter GT-repeat (RR = 2. 185; 95 {\%} CI = 1.527-3.125), and G6PD deficiency (RR = 1.985; 95 {\%} CI = 1.010-3.901). The other gene variants - including blood type, alpha thalassemia, and SLCO1B1 - carried no significant risk. Conclusions: G6PD deficiency, short HO-1 promoter GT-repeat and GA at nt211 in UGT1A1 are risk factors of neonatal hyperbilirubinemia. The data provide clinical evidence to explain the high incidence of neonatal hyperbilirubinemia in Taiwan.",
keywords = "Heme oxygenase-1, Hepatic solute carrier organic anion transporter 1B1, Neonatal hyperbilirubinemia, Thalassemia, UDP-glucuronosyltransferase 1A1",
author = "Weng, {Yi Hao} and Chiu, {Ya Wen} and Cheng, {Shao Wen} and Yang, {Chun Yuh}",
year = "2016",
doi = "10.1186/s12887-016-0685-8",
language = "English",
volume = "16",
journal = "BMC Pediatrics",
issn = "1471-2431",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan

AU - Weng, Yi Hao

AU - Chiu, Ya Wen

AU - Cheng, Shao Wen

AU - Yang, Chun Yuh

PY - 2016

Y1 - 2016

N2 - Background: Hyperbilirubinemia is a common disorder during neonatal period in Taiwan. Gene variants may play an important role in the development of neonatal hyperbilirubinemia. The current study investigated the association between neonatal hyperbilirubinemia and common gene variants involving the production and metabolism of bilirubin. Methods: This prospective study enrolled 444 healthy infants born in the Chang Gung Memorial Hospital at Taipei from 2013-2015. Hyperbilirubinemia was defined as a total bilirubin = 15 mg/dL. A log-binomial model was used to assess the risk of gene variants. Results: The most common genetic variant was short heme oxygenase (HO)-1 promoter GT-allele (<24 repeats) (39.4 %), followed by GA at nt388 in hepatic solute carrier organic anion transporter 1B1 (SLCO1B1) (31.1 %), GA at nt211 in UDP-glucuronosyltransferase 1A1 (UGT1A1) (29.3 %), ABO incompatibility (16.2 %), alpha thalassemia (5.0 %), and G6PD deficiency (3.2 %). The log-binomial analysis demonstrated greater risks of hyperbilirubinemia in infants with GA at nt211 in UGT1A1 (RR = 1.548; 95 % CI = 1.096-2.187), short HO-1 promoter GT-repeat (RR = 2. 185; 95 % CI = 1.527-3.125), and G6PD deficiency (RR = 1.985; 95 % CI = 1.010-3.901). The other gene variants - including blood type, alpha thalassemia, and SLCO1B1 - carried no significant risk. Conclusions: G6PD deficiency, short HO-1 promoter GT-repeat and GA at nt211 in UGT1A1 are risk factors of neonatal hyperbilirubinemia. The data provide clinical evidence to explain the high incidence of neonatal hyperbilirubinemia in Taiwan.

AB - Background: Hyperbilirubinemia is a common disorder during neonatal period in Taiwan. Gene variants may play an important role in the development of neonatal hyperbilirubinemia. The current study investigated the association between neonatal hyperbilirubinemia and common gene variants involving the production and metabolism of bilirubin. Methods: This prospective study enrolled 444 healthy infants born in the Chang Gung Memorial Hospital at Taipei from 2013-2015. Hyperbilirubinemia was defined as a total bilirubin = 15 mg/dL. A log-binomial model was used to assess the risk of gene variants. Results: The most common genetic variant was short heme oxygenase (HO)-1 promoter GT-allele (<24 repeats) (39.4 %), followed by GA at nt388 in hepatic solute carrier organic anion transporter 1B1 (SLCO1B1) (31.1 %), GA at nt211 in UDP-glucuronosyltransferase 1A1 (UGT1A1) (29.3 %), ABO incompatibility (16.2 %), alpha thalassemia (5.0 %), and G6PD deficiency (3.2 %). The log-binomial analysis demonstrated greater risks of hyperbilirubinemia in infants with GA at nt211 in UGT1A1 (RR = 1.548; 95 % CI = 1.096-2.187), short HO-1 promoter GT-repeat (RR = 2. 185; 95 % CI = 1.527-3.125), and G6PD deficiency (RR = 1.985; 95 % CI = 1.010-3.901). The other gene variants - including blood type, alpha thalassemia, and SLCO1B1 - carried no significant risk. Conclusions: G6PD deficiency, short HO-1 promoter GT-repeat and GA at nt211 in UGT1A1 are risk factors of neonatal hyperbilirubinemia. The data provide clinical evidence to explain the high incidence of neonatal hyperbilirubinemia in Taiwan.

KW - Heme oxygenase-1

KW - Hepatic solute carrier organic anion transporter 1B1

KW - Neonatal hyperbilirubinemia

KW - Thalassemia

KW - UDP-glucuronosyltransferase 1A1

UR - http://www.scopus.com/inward/record.url?scp=85008315455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008315455&partnerID=8YFLogxK

U2 - 10.1186/s12887-016-0685-8

DO - 10.1186/s12887-016-0685-8

M3 - Article

C2 - 27557546

AN - SCOPUS:85008315455

VL - 16

JO - BMC Pediatrics

JF - BMC Pediatrics

SN - 1471-2431

IS - 1

M1 - 144

ER -